Filing Flows › Health Care › Warby Parker (WRBY)
Warby Parker (WRBY) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Warby Parker (WRBY) Q3 2026 earnings results →
Q3 2026 Revenue up 10% year over year to $245M · 2¢ of every $1 of revenue kept as net profit · operating margin 1.5%
Warby Parker made $245M in Q3 2026 (+10% Y/Y): Eyewear $198M, Contacts $27.9M, Eye care $18.8M. Operating margin 1.5%, net earnings $5.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $244.7M in Q3 2026, up 10% year over year and up 4% from the previous quarter. Eyewear was the largest line at 81% of revenue. Eyewear added $16.4M year over year (up 9%), 71% of the total change.
Gross margin was 54.4%, up 0.3 points from Q3 2025. Operating profit was $3.6M, a 1.5% margin (down 0.2 points year over year). Operating profit fell $13K even though revenue rose $23.1M versus Q3 2025, so costs grew faster than sales. Operating expenses grew 11% against revenue growth of 10%. Net earnings were $5.6M, down 5% year over year. The effective tax rate was 9.1%. Non-operating items added $2.6M, 42% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $24.7M (up 38% year over year), 441% of net earnings. Non-cash charges added back $14.4M of depreciation and amortization and $8.5M of share-based compensation. Working capital and other items used $3.9M. Capital expenditures of $26.7M exceeded it, leaving free cash flow of −$2.0M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 5, 2026 | $245M | +10% | 1.5% | $5.6M | $24.7M |
| Q2 2026 | 10-Q | Aug 6, 2026 | $236M | +10% | 1.3% | $4.6M | $29.6M |
| Q1 2026 | 10-Q | May 7, 2026 | $242M | +8% | 0.7% | $3.2M | $24.5M |
| Q4 2025 | 10-K | Feb 26, 2026 | $212M | +11% | -3.2% | −$6.0M | $23.3M |
| Q3 2025 | 10-Q | Nov 6, 2025 | $222M | +15% | 1.6% | $5.9M | $18.0M |
| Q2 2025 | 10-Q | Aug 8, 2025 | $214M | +14% | -2.1% | −$1.8M | $40.2M |
| Q1 2025 | 10-Q | May 8, 2025 | $224M | +12% | 1.1% | $3.5M | $29.4M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Buys from
- AFRM · Stated in 10-K (named, share not stated) · source
- AMZN · Stated in 10-K (named, share not stated) · source
- PYPL · Stated in 10-K (named, share not stated) · source
About Warby Parker
Warby Parker is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. We stand for fun, creativity, and doing good in the world. Every day, our team of over 4,000 employees is focused on our mission to inspire and impact the world with vision, purpose, and style (without charging a premium for it). Our ultimate objective is to provide vision for all. As a pioneer of the direct-to-consumer model, we design our glasses in-house at our New York City headquarters and sell directly to customers, enabling us to make high-quality, designer eyewear more accessible, with simple, unified pricing starting at $95 including prescription lenses.
In its own words, from its 10-K, filed Feb 26, 2026.
Warby Parker against its Ophthalmic Goods peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +10% against the peers' median +2%. Operating margin: 1.5% against the peers' median 4.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| WRBY Warby Parker | Q3 2026 | $245M | +10% | 1.5% |
| BLCO Bausch & Lomb | Q3 2026 | $1.4B | +7% | 11.3% |
| COO Cooper Companies | Q3 FY26 | $1.1B | +0.6% | 20.8% |
| EYE National Vision Holdings | Q2 2026 | $499M | +2% | 4.3% |
| STAA Staar Surgical | Q3 2026 | $83.4M | -12% | 6.5% |
| RXST RxSight | Q3 2026 | $24.6M | -19% | -75.3% |
| LUCYW Innovative Eyewear | Q2 2026 | $1.0M | +74% | -165.3% |
Source: Warby Parker 10-Q on SEC EDGAR · CIK 1504776 · Ophthalmic Goods
Guidance and outlook
13F: who owns WRBY and who is buying
More on WRBY
- How Warby Parker makes money: revenue by segment
- Warby Parker next earnings date and what analysts expect
- Warby Parker stock forecast, price target and fair value
- Who owns Warby Parker stock: holders, funds and Congress trades
- Warby Parker guidance and outlook
- Is Warby Parker a takeover target? LBO and rumors
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Warby Parker guidance history: guided vs reported
- Warby Parker gross margin by quarter
- Warby Parker operating margin by quarter
- Warby Parker net income by quarter
- Warby Parker free cash flow by quarter
- Warby Parker capital expenditures by quarter
- Warby Parker Eyewear revenue by quarter
- Warby Parker Contacts revenue by quarter
- Warby Parker Eye care revenue by quarter